Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hoechst/Copley's generic micronized glyburide turned down by Illinois formulary.

Executive Summary

HOECHST/COPLEY MICRONIZED GLYBURIDE TURNED DOWN BY ILLINOIS FORMULARY committee May 31 after Upjohn testified that the Copley generic does not use the same scoring in its tablet design as Upjohn's Glynase PresTabs, the brand equivalent. Hoechst-Roussel manufactures the generic, which is distributed by Copley, its majority-owned affiliate. Hoechst plans to appeal the Illinois decision.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS026403

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel